Redirecting to https://markets.businessinsider.com/news/stocks/beyondspring-announces-esmo-asia-presentation-on-plinabulin-docetaxel-improving-survival-in-large-phase-3-dublin-3-asian-subset-for-egfr-wt-nsclc-compared-to-docetaxel-strengthening-the-case-for-1035640466